Your cart is empty.
|Wendy Lauber, Global Marketing Manager BioPharma from Tecan receives the award|
The Tecan Group was presented with the prestigious 2006 Frost & Sullivan Award for Vertical Market Penetration Leadership at the 2006 Excellence in Healthcare Awards Banquet in London’s Whitehall. The glittering awards presentation ceremony is hosted annually by Frost & Sullivan to honor companies for their achievements in the drug discovery technologies, healthcare and life sciences IT, medical imaging, patient monitoring and medical devices arenas.
Tecan was presented with the award in recognition of its strong degree of market presence and competitive advantage throughout its range of product areas, including automated liquid handling, microplate readers, robotics systems and automated sample storage systems. Frost & Sullivan congratulated Tecan for its outstanding ability to provide end-to-end functionality with its instruments which, by bridging the gap between laboratory technologies and drug discovery, may help to accelerate early stage drug development processes.
Tecan’s successful market penetration is partly the result of its emphasis on customer partnership; the company believes in striving to meet all its customers’ needs by providing flexible and scalable laboratory products that can be integrated into one common platform with user-friendly software. Thanks to Tecan’s diligence, perseverance and dedication, the company has excelled in the increasingly competitive global market.
Tecan Switzerland AG
Seestrasse 103, CH-8708 Männedorf
T +41 44 922 81 11, F +41 44 922 81 12
Tecan (www.tecan.com) is a leading global player in the Life Sciences supply industry specializing in the development, production, and distribution of advanced automation solutions enabling pharma and academic research, diagnostics, food and veterinary research as well as forensics. Through its REMP subsidiary (www.remp.com), Tecan is the leading supplier of compound and sample storage, management and logistics solutions. Tecan clients are pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2005, Tecan achieved sales of CHF 344.9 million (USD 275.9 Mio.; EUR 222.5 Mio.). Registered shares of Tecan Group are traded on the SWX Swiss Exchange (TK: TECN / Reuters: TECZn.S / Valor: 1210019).